EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fueling the fire: aspartate deficiency primes and fuels STING activation

Haitao Jiang, Wenyan Wang, Yang-Xin Fu

Journal of Clinical Investigation · 01.06.2026 · 136 (11)

DOI: 10.1172/jci206431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.06.2026. Verfasst von Haitao Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, School of Medicine, and. Hauptthemen laut MEDLINE: Aspartic Acid, STING Protein. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytosolic DNA sensing through the cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway has emerged as a promising strategy to elicit antitumor immunity. However, clinical translation of STING agonists has been hindered by limited efficacy and dose-limiting inflammatory toxicity, highlighting that simply providing activating ligands is insufficient to achieve durable immune responses. In this issue of the Journal of Clinical Investigation , Liao et al. showed that intracellular aspartate availability critically shapes STING signaling responsiveness. Aspartate deficiency disrupted pyrimidine synthesis, induced mtDNA stress, and engaged a feed-forward Z-DNA binding protein 1 and receptor interacting serine/threonine kinase 1/3 axis. Rather than directly triggering immunity, this metabolic state primed DNA sensing and fueled downstream signaling, thereby enabling robust and sustained antitumor immune responses. Together, these findings position nucleotide metabolism as a key determinant of innate immune responsiveness and suggest that metabolic conditioning may enhance the efficacy of STING-targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspartic AcidSTING ProteinHumanscGAS-STING Signaling PathwayImmunity, InnateSignal TransductionDNA, MitochondrialNeoplasmsMolecular Targeted Therapy

Substanzen

Aspartic AcidSTING1 protein, humanSTING ProteinDNA, Mitochondrial

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, School of Medicine, and.
  • State Key Laboratory of Molecular Oncology, Tsinghua University, Beijing, China.
  • Changping Laboratory, Beijing, China.

Zitieren

APA

Jiang, H., Wang, W., & Fu, Y. X. (2026). Fueling the fire: aspartate deficiency primes and fuels STING activation. Journal of Clinical Investigation, 136(11). https://doi.org/10.1172/jci206431

Vancouver

Jiang H, Wang W, Fu YX. Fueling the fire: aspartate deficiency primes and fuels STING activation. Journal of Clinical Investigation. 2026;136(11). doi:10.1172/jci206431

BibTeX
@article{Jiang2026,
  author = {Jiang, Haitao and Wang, Wenyan and Fu, Yang-Xin},
  title = {Fueling the fire: aspartate deficiency primes and fuels STING activation},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {11},
  doi = {10.1172/jci206431}
}
Kostenlos starten →